Arkansas gets donation of Trump-promoted anti-malarial drug

Arkansas News

In this Wednesday, April 8, 2020 photo provided by the Center for Pharmaceutical Research, a participant in a COVID-19 coronavirus vaccine trial receives an injection in Kansas City, Mo. This early safety study, called a Phase 1 trial, is using a vaccine candidate developed by Inovio Pharmaceuticals. (Center for Pharmaceutical Research via AP)

LITTLE ROCK, Ark. (AP) — A pharmaceutical company has given Arkansas 100,000 tablets of an anti-malarial drug that President Donald Trump is heavily pitching as a treatment for coronavirus. Lt. Gov. Tim Griffin and the University of Arkansas for Medical Sciences announced the donation of hydroxychloroquine from Amneal.

The pharmaceutical company has announced similar donations to other states. Arkansas health officials say the number of coronavirus cases in the state has reached at least 1,071, with 18 deaths.

Hydroxychloroquine has long been used to treat malaria, rheumatoid arthritis and lupus.

Health experts say more studies are needed to determine whether it’s safe and effective.

Stay up to date with the latest news by downloading the KTVE/KARD News App from the App Store or Google Play.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

Don't Miss

Trending Stories